Factors associated with dyspnea in adult patients with sickle cell disease

被引:51
作者
Delclaux, C
Zerah-Lancner, F
Bachir, D
Habibi, A
Monin, JL
Godeau, B
Galacteros, F
机构
[1] Hop Henri Mondor, Assistance Publ Hop Paris, Serv Physiol, Creteil, France
[2] Hop Henri Mondor, Assistance Publ Hop Paris, Ctr Drepanocytose, Creteil, France
[3] Hop Henri Mondor, Assistance Publ Hop Paris, Serv Cardiol, Creteil, France
[4] Hop Henri Mondor, Assistance Publ Hop Paris, Serv Med Interne, Creteil, France
关键词
dyspnea; lung diffusion of carbon monoxide; 6-min walk test; pulmonary capillary blood volume; sickle cell disease;
D O I
10.1378/chest.128.5.3336
中图分类号
R4 [临床医学];
学科分类号
1002 [临床医学]; 100602 [中西医结合临床];
摘要
Objective: The aim of this prospective study was to determine the cardiorespiratory factors associated with dyspnea in patients with sickle cell SS-hemoglobin disease, with a specific interest in lung vascular involvement. Measurements: Forty-nine patients (29 women and 20 men; mean [+/- SD] age: women, 29 +/- 6 years; men, 31 +/- 11 years) underwent direct evaluations (Borg scale evaluation during a 6-min walk test) and indirect evaluations (modified Medical Research Council [MRC]score) of their dyspnea, pulmonary function tests (PFTs) [spirometry, volumes, diffusing capacity of the lung for carbon monoxide (DLCO), diffusing capacity of the alveolar-capillary membrane, and pulmonary capillary blood volume measurements], echocardiography, and biological evaluation. Results: Thirty-four patients complained of significant breathlessness (MRC score, > 1). Indirect and direct evaluations of dyspnea were correlated. PFT results depicted a very mild restrictive pattern (mean total pulmonary capacity, 86 +/- 11% predicted) and an impairment of DLCO (mean DLCO corrected for the degree of anemia, 69 +/- 13% predicted). The statistical analysis demonstrated that dyspnea and exercise performance were closely linked to indexes of DLCO but not with any echocardiographic or biological measure including anemia. Nevertheless, only approximately 25% of the variability was explained by these associations. Despite having a similar history of vasoocclusive crisis events, women had more severe anemia, dyspnea, decreases in DLCO (corrected for the degree of anemia), and a higher capillary blood volume (corrected for alveolar volume) than men. Conclusion: Lung vascular disease contributes to dyspnea and the exercise limitation of patients with sickle cell disease. A sequential assessment of DLCO would therefore constitute one of the objective functional end points for follow-up studies of these patients.
引用
收藏
页码:3336 / 3344
页数:9
相关论文
共 33 条
[1]
[Anonymous], 1995, AM J RESP CRIT CARE, V152, P2185
[2]
[Anonymous], 1999, Am J Respir Crit Care Med, V160, P2104
[3]
[Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107
[4]
THE PAINFUL CRISIS OF HOMOZYGOUS SICKLE-CELL DISEASE - A STUDY OF RISK-FACTORS [J].
BAUM, KF ;
DUNN, DT ;
MAUDE, GH ;
SERJEANT, GR .
ARCHIVES OF INTERNAL MEDICINE, 1987, 147 (07) :1231-1234
[5]
Cardiopulmonary responses to exercise in women with sickle cell anemia [J].
Callahan, LA ;
Woods, KF ;
Mensah, GA ;
Ramsey, LT ;
Barbeau, P ;
Gutin, B .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 165 (09) :1309-1316
[6]
ALTERED CYTOKINE RELEASE IN PERIPHERAL-BLOOD MONONUCLEAR CELL-CULTURES FROM PATIENTS WITH THE CHRONIC FATIGUE SYNDROME [J].
CHAO, CC ;
JANOFF, EN ;
HU, SX ;
THOMAS, K ;
GALLAGHER, M ;
TSANG, M ;
PETERSON, PK .
CYTOKINE, 1991, 3 (04) :292-298
[7]
IRON-DEFICIENCY ANEMIA - ITS EFFECT ON TRANSFER FACTOR FOR LUNG (DIFFUSING CAPACITY) AND VENTILATION AND CARDIAC FREQUENCY DURING SUB-MAXIMAL EXERCISE [J].
COTES, JE ;
DABBS, JM ;
SAUNDERS, MJ ;
HALL, AM ;
ELWOOD, PC ;
MCDONALD, A .
CLINICAL SCIENCE, 1972, 42 (03) :325-+
[8]
ATS statement: Guidelines for the six-minute walk test [J].
Crapo, RO ;
Casaburi, R ;
Coates, AL ;
Enright, PL ;
MacIntyre, NR ;
McKay, RT ;
Johnson, D ;
Wanger, JS ;
Zeballos, RJ ;
Bittner, V ;
Mottram, C .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 166 (01) :111-117
[9]
Croizat H, 1999, AM J HEMATOL, V60, P105, DOI 10.1002/(SICI)1096-8652(199902)60:2<105::AID-AJH4>3.0.CO
[10]
2-Z